Gene · 9235
Papers3,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overexpression of NK4 gene in TU212 affects migratory activity in laryngeal squamous cell carcinoma. | Front Oncol | 2025 | 40823073 | PubTator, text mining | PubMed |
| Emerging cytokines contribute to the clinical manifestation of carotid artery plaque formation and stability in patients with diabetes. | Atheroscler Plus | 2025 | 40809805 | PubTator, text mining | PubMed |
| Severity-specific immune landscape of COVID-19 revealed by single-cell sequencing. | Sci Rep | 2025 | 40796616 | PubTator, text mining | PubMed |
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Correction to: IL-32 regulates trophoblast invasion through miR-205-NFκB-MMP2/9 axis contributing to the pregnancy-induced hypertension. | Biol Reprod | 2025 | 40761000 | PubTator, text mining | PubMed |
| The spatial landscape of glial pathology and T cell response in Parkinson's disease substantia nigra. | Nat Commun | 2025 | 40759663 | PubTator, text mining | PubMed |
| ACE: A Versatile Contrastive Learning Framework for Single-cell Mosaic Integration. | Genomics Proteomics Bioinformatics | 2025 | 40757914 | PubTator, text mining | PubMed |
| IL-32 positively regulates the AEBP1-IκBα-NF-κB-TNF-α axis to inhibit Mycobacterium tuberculosis infection in human macrophages. | Microb Pathog | 2025 | 40752529 | PubTator, text mining | PubMed |
| Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy. | Int J Oral Sci | 2025 | 40750580 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of H1-antihistamines in endometriosis-A gene regulation-based perspective. | Front Med (Lausanne) | 2025 | 40747097 | PubTator, text mining | PubMed |
| Natural killer cell as a potential predictive biomarker for early immune checkpoint inhibitor-associated cardiovascular adverse events: a retrospective cohort study. | Front Oncol | 2025 | 40740863 | PubTator, text mining | PubMed |
| Comprehensive insight on immune landscape in intracerebral hemorrhage patients with single-cell RNA sequencing: from blood to hematoma. | J Neuroinflammation | 2025 | 40739271 | PubTator, text mining | PubMed |
| High-Risk PNPLA3 rs738409 Genotype Is Associated with Higher Concentrations of CCL2 in Liver Transplant Candidates with Alcoholic End-Stage Liver Disease. | Medicina (Kaunas) | 2025 | 40731922 | PubTator, text mining | PubMed |
| The Associations of Air Pollution Mixture Exposure with Plasma Proteins in an Elderly U.S. Panel. | Environ Sci Technol | 2025 | 40704984 | PubTator, text mining | PubMed |
| Correction: IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells. | Hum Cell | 2025 | 40694194 | PubTator, text mining | PubMed |
| Systemic and tumor-specific inflammatory markers VCAM-1 and ICAM-1 as indicators of extent of surgery and oncologic outcome in advanced ovarian cancer. | Transl Oncol | 2025 | 40652770 | PubTator, text mining | PubMed |
| Hypoxia-induced activation of calpain and oxidative stress in mitochondria leads to RGC death in human iPSC-derived retinal organoids. | Exp Eye Res | 2025 | 40651649 | PubTator, text mining | PubMed |
| Interleukin-32-expressing CD4+ T cells are a potentially pathogenic subset in systemic sclerosis with interstitial lung disease. | Respir Investig | 2025 | 40617174 | PubTator, text mining | PubMed |
| IL1A: a novel prognostic biomarker and potential therapeutic target for renal clear cell carcinoma. | Oncol Res | 2025 | 40612864 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing: new insights for pulmonary endothelial cells. | Front Cell Dev Biol | 2025 | 40599812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9235/papers?page=7